PARIS — At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360.  It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging.  ParaVision 360 enables sequential or simultaneous PET/MR measurements and analysis in […]

How are my cells doing? PAULA, the world’s first Personal AUtomated Lab Assistant, always knows the answer! PAULA, the world’s first Personal AUtomated Lab Assistant from Leica Microsystems, is ready to help out cell-lab users. As a new member of the team, PAULA would take over a large number of time-consuming, routine manual tasks that […]

Adelaide: RHS Limited (ASX: RHS) (“RHS” or “the Company”) is pleased to announce that the scheme of arrangement between RHS and its shareholders (“Scheme”) has today been implemented. Implementation follows approval of the Scheme by RHS shareholders at the Scheme meeting held on 22 May 2018 and by the Federal Court of Australia on 29 […]

COPAS Vision, our newest large particle flow cytometer, adds brightfield imaging to our large particle sorting capabilities. As with our original COPAS platform of flow cytometers it provides automated high throughput analysis and sorting of viable multicellular organisms, cell clusters, bead-based libraries and other samples that are too large or too fragile for traditional flow […]

BILLERICA, Mass. — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT practical and truly useful for industrial and […]

To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]

Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform   Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]

New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, MA, USA — Some of today’s most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are […]

Utrecht, The Netherlands Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. “We are extremely excited to welcome Quad Technologies and its line of advanced […]